Výsledky vyhledávání - "Miguel Navarro Martín"

Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO)

Publikováno v: TARGETED ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-FISABIO. Repositorio Institucional de Producción Científica
Digital.CSIC. Repositorio Institucional del CSIC
Targeted Oncology
r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón

[Background]: The cell cycle checkpoint G1/S, dependent on cyclin-dependent kinase (CDK) 4 amplification/overexpression and retinoblastoma phosphorylation, is altered in most anaplastic oligodendrogliomas (AOs). [Objective]: We aimed to evaluate the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::815aef705a238f3bad753381a3c1ca47
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=12522

Zobrazit plný text záznamu

Renal Cell Carcinoma Associated With Xp11.2 Translocation/TFE3 Gene-fusion: A Long Response to mammalian target of rapamycin (mTOR) Inhibitors

Autor: Juan J. Cruz Hernández, Roberto Andrés Escala Cornejo, Aracely Rocío García Dominguez, Oliver R. Rua Fernández, María García Muñoz, Miguel Navarro Martín, Patricia Antunez Plaza

Publikováno v: Digital.CSIC: Repositorio Institucional del CSIC
Consejo Superior de Investigaciones Científicas (CSIC)
Digital.CSIC. Repositorio Institucional del CSIC
instname

[Objective]: To demonstrate that patients with Xp11.2/TFE3 gene-fusion translocation renal cell carcinoma (RCC), despite having an aggressive course in young adults, could have valid treatment options such as mammalian target of rapamycin (mTOR) inhi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f881ffb65666918304bea1ae28e8a6f
https://doi.org/10.1016/j.urology.2018.03.032

Zobrazit plný text záznamu

Large cell neuroendocrine carcinoma of the lung with atypical evolution and a remarkable response to lutetium Lu 177 dotatate

Autor: Roberto Andrés Escala Cornejo, Paloma García-Talavera, Ma Pilar Tamayo Alonso, Berta Pérez López, María García Muñoz, Miguel Navarro Martín, Juan J. Cruz Hernández

Publikováno v: Annals of nuclear medicine. 32(8)

Large cell neuroendocrine carcinoma of the lung (LCNEC) is a high-grade, poorly differentiated tumor that typically does not express somatostatin receptors. Thus, it does not benefit from treatment with somatostatin analogs and peptide receptor radio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b59aeb7f833d063fa66384a640f82a1
https://pubmed.ncbi.nlm.nih.gov/30051167

Zobrazit plný text záznamu

Durable clinical benefit with exemestane in leptomeningeal metastasis of breast cancer

Autor: Luis Miguel Navarro Martín, Juan Jesús Cruz Hernández, Alberto Ocaña Fernández, Isabel Ruiz Martín, César A. Rodríguez Sánchez

Publikováno v: Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 7(8)

Since most chemotherapy agents do not cross the blood brain barrier, the classical approach for leptomeningeal metastasis (LM) of breast cancer is the administration of cranial intra-ventricular chemotherapy. The roles of hormonal agents like tamoxif

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3860f544f0af5395fb0d6b280731473a
https://pubmed.ncbi.nlm.nih.gov/16185606

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání